MET and laryngeal carcinoma: Analogous phenomenon was noticed by Lee and co-workers who showed that ME22S (a novel EGFR/MET bispecific antibody) significantly inhibited HGF-stimulated migration and invasion of laryngeal carcinoma cells (Lee et al., 2016).